SupplementsEvidence ReviewAug 2026

Oral Glutathione Supplements: Does Swallowing It Actually Raise Your Levels?

If you are holding a bottle labelled glutathione 2000mg and wondering whether any of it survives your stomach, that question has been argued in the literature since 1992 and the answer turns on what you measure and for how long. One big dose does close to nothing. Six months of daily capsules does raise what your body stores. Both findings are real, they come from different trials, and a product page will quote whichever one suits the bottle.

3 g

Single dose that moved nothing in 1992

30 to 35%

Blood store rise at 1,000 mg over 6 months

2 of 6

Skin sites that beat placebo in the Bangkok trial

This page is educational and not medical advice. It reports what specific human trials measured and what their authors concluded. It does not tell you to take glutathione, to stop taking it, or what amount to use. Anything about your own body belongs with a doctor or a pharmacist who can see your situation.

What Happens When You Swallow It

Glutathione is a tripeptide, three amino acids joined in a chain, and your own cells build it constantly. Park and colleagues write its full chemical name as gamma-L-glutamyl-L-cysteinyl-glycine, which is the same molecule a label prints as L-glutathione or reduced glutathione, usually shortened to GSH.

The trouble with swallowing a peptide is that your gut is built to take peptides apart. In 1992 Witschi and colleagues at the University of Bern gave 7 healthy volunteers a single oral dose of 0.15 mmol per kg, which they describe in their own conclusion as 3 g, and then watched plasma for 270 minutes. Glutathione, cysteine and glutamate did not rise significantly. They put it down to hydrolysis by gamma-glutamyltransferase in the intestine and the liver, and concluded that systemic availability of glutathione is negligible in man.

Read that sentence carefully. Their conclusion is scoped to a single dose, in 7 people, watched for 270 minutes. Stretching it into proof that oral glutathione does nothing, ever, is more than the authors wrote, and the research that came after turns on exactly that gap between one swallow and months of them.

Does It Raise Your Levels

Three trials answer this and they do not agree, which is the honest state of the field rather than a problem with any of them.

Allen and Bradley ran a randomised, double-blind, placebo-controlled trial in 40 adult volunteers without acute or chronic disease, randomised between glutathione and placebo, so roughly 20 people took the supplement. The dose was 500 mg twice daily for 4 weeks and 39 finished per protocol. Urinary F2-isoprostanes and 8-hydroxy-2-deoxyguanosine did not budge, and total reduced glutathione, oxidised glutathione and their ratio in red blood cells were also unchanged. Nothing moved.

Richie and colleagues ran it for six times as long. Their 6-month randomised double-blind placebo-controlled trial enrolled 54 non-smoking adults spread across a 250 mg per day group, a 1,000 mg per day group and a placebo group, which makes each arm small. At 6 months in the 1,000 mg group, mean glutathione was 30 to 35 percent higher in red blood cells, plasma and lymphocytes, and 260 percent higher in buccal cells from the inside of the cheek. The 250 mg group rose 17 percent in whole blood and 29 percent in red blood cells. Natural killer cell cytotoxicity more than doubled against placebo in the high-dose group at 3 months, and the ratio of oxidised to reduced glutathione in whole blood fell in both dose groups after 6 months. The detail most product pages skip: levels went back to baseline after a one-month washout.

Then Park and colleagues showed that the standard measurement may be looking in the wrong pocket. They gave healthy volunteers 50 mg per kg orally, which works out at roughly 3 g for a 60 kg adult, and found no significant difference in the deproteinised plasma fraction or the blood cell fraction, which is what most studies measure. But glutathione in the protein-bound fraction of plasma rose significantly, at P below 0.01, between 60 and 120 minutes after the dose. That is not evidence of a benefit. It is an explanation for why two careful labs can run the same experiment and report opposite headlines.

Trial	Amount and duration	What they found
Witschi 1992, 7 healthy volunteers	3 g, one dose, watched 270 min	No significant rise in plasma glutathione, cysteine or glutamate
Allen 2011, 40 randomised, adults with no acute or chronic disease	500 mg twice daily, 4 weeks	No change in oxidative stress markers or red cell glutathione
Richie 2015, 54 non-smoking adults, three arms	250 or 1,000 mg daily, 6 months	Up 30 to 35 percent at the high dose, back to baseline after a 1-month washout
Park 2014, healthy volunteers	50 mg per kg, one dose	Free plasma and blood cell fractions unchanged, protein-bound plasma fraction up at 60 to 120 min

Line those up and a pattern shows: 1,000 mg per day for 4 weeks changed nothing in Allen, and the same 1,000 mg per day for 6 months moved red cells, plasma and lymphocytes in Richie. Duration looks like it matters at least as much as the number on the capsule. That is a comparison across two separate trials with different populations and different assays, so treat it as the shape of the evidence rather than a settled fact.

The Number On The Bottle

The milligram figure on the front of the box is the thing most people compare, and it is the weakest basis for a comparison on this page. The human trials cluster in a fairly narrow band, and it sits below the largest numbers these products are marketed at.

250 mg and 1,000 mg daily: the two amounts Richie tested for body stores over 6 months.
250 mg once daily, 250 mg twice daily and 500 mg once daily: the amounts in the oral trials a 2025 systematic review gathered for skin melanin index.
1,000 mg daily for 4 weeks: the amount that changed nothing in Allen and Bradley.
3 g as one dose: the amount that changed nothing over 270 minutes in Witschi.

A 2,000 mg serving sits above every daily amount in that published set. That makes it untested for these outcomes, which is a different thing from stronger and a different thing from unsafe. It is a gap in the evidence, and a bottle cannot fill a gap by printing a bigger number on itself.

One label detail worth knowing while you are comparing: L-glutathione and reduced glutathione mean the same molecule the trials used. Weschawalit and colleagues also tested the oxidised form, written GSSG, at 250 mg per day alongside the reduced form, so both appear in the literature. What amount suits any particular person is a question for a pharmacist or a doctor, not for a guide.

The Skin-Lightening Question

This is the reason most people pick the bottle up, and it is also where the research happens to live. Every oral glutathione skin trial cited on this page was run in Southeast Asia, on Southeast Asian participants: Thailand, the Philippines and Indonesia. For a reader in Vietnam that makes them closer to home than most supplement literature. Read them closely, though, because each one is more careful than the summaries built on top of it.

Bangkok, 4 weeks, 60 medical students

Arjinpathana and Asawanonda randomised 60 otherwise healthy medical students at King Chulalongkorn Memorial Hospital to 500 mg per day in two divided doses or to placebo, so around 30 per arm. Melanin indices fell at all six measured sites in the glutathione group, and the fall was statistically greater than placebo at two of those six: the right side of the face at p equal to 0.021 and the sun-exposed left forearm at p equal to 0.036. Their own conclusion is that oral glutathione lightens skin colour in a small number of subjects, and that long-term safety has not been established.

Thailand, 12 weeks, healthy women

Weschawalit and colleagues randomised healthy female subjects three ways, to 250 mg per day of the reduced form, 250 mg per day of the oxidised form, or placebo. Melanin index and ultraviolet spots tended to be lower than placebo, and tended is the authors' word, not a significant result. What did reach significance was a reduction in wrinkles with the reduced form at some of the sites evaluated, alongside a tendency toward increased skin elasticity.

Philippines, 8 weeks, 30 women, no control group

Handog and colleagues gave 30 Filipino women with Fitzpatrick skin type IV or V a glutathione lozenge daily for 8 weeks and saw melanin indices fall significantly from as early as 2 weeks. Two caveats sit on top of that. It was open-label and single-arm, so there was no placebo group to compare against, and a lozenge dissolved in the mouth was the entire point of the study, chosen to bypass the gut rather than to test a swallowed capsule.

Two systematic reviews then tried to add these up. Dilokthornsakul and colleagues pooled four studies and found that oral glutathione at 500 mg per day and a topical 2 percent oxidised glutathione could brighten sun-exposed skin on the melanin index, while no product produced a significant reduction in sun-protected areas. Their conclusion is that current evidence for a skin-whitening effect remains inconclusive because of the quality of the included studies and inconsistent findings, though there is a trend toward brightening in sun-exposed areas. Both halves of that sentence belong together.

A 2025 review by Sarkar and colleagues states that five randomised controlled trials and one open-arm study of oral glutathione, at 250 mg once daily, 250 mg twice daily and 500 mg once daily, showed a significant reduction in the melanin index compared to placebo. That sentence is the review's own summary, and two of the primary trials described above on this page do not carry it: Weschawalit, the 250 mg per day trial, reported the melanin index only as tending to be lower than placebo, and the Handog study was open-arm with no placebo group to be compared against at all. The third does carry it, but narrowly. Arjinpathana, which is the 250 mg twice a day arm in that list, beat placebo on the melanin index at two of the six sites measured, not across the board. In the same review, the risk-of-bias assessment put almost as many studies at high risk as at low risk, and the review describes the skin-lightening outcomes from both oral and topical glutathione as unsustainable.

The part the marketing leaves out. Three independent sources say the effect does not stick. Richie found blood levels back at baseline one month after stopping. Sarkar calls the skin outcomes unsustainable. Sonthalia and colleagues describe the oral, sublingual and topical results on skin tone as appreciable but reversible. None of the skin trials on this page ran longer than 12 weeks, so what happens over a year is not something anyone here can tell you.

Glutathione With Vitamin C

Glutathione is often sold paired with vitamin C, and one trial tested close to exactly that product. Sitohang and colleagues ran an Indonesian multicentre randomised, double-blind, controlled trial across three teaching-hospital dermatology clinics, registered as NCT04105504. The supplement combined L-glutathione produced by fermentation with ascorbic acid, alpha-lipoic acid and zinc as zinc aspartate, against placebo capsules, with assessments every 4 weeks over 12 weeks using a Janus facial analysis system.

83 participants aged between 33 and 50 completed the study, split between the supplement arm and the placebo arm, so roughly 40 people took the combination. Reductions in ultraviolet spots in certain subgroups, in spot polarisation and in skin tone were greater in the supplement group than in the placebo group, but the difference was not statistically significant. The authors concluded that the supplement was slightly beneficial for skin lightening in particular subgroups, that the results were not statistically significant, and that further research is required. Both groups experienced only mild side effects in the first 4 weeks. The registry record lists the trial as completed, with an actual enrolment of 90 across two arms.

There is a second problem with combination products that no trial design can fix cheaply. That capsule held four active ingredients. Even a clean positive result would not have told you which one earned it, and a null result does not clear any single ingredient either. If you want the reasoning behind a similar pairing question in skincare, the same logic runs through the retinol guide.

Sublingual, Lozenge, Liposomal, IV

If the gut is the obstacle, the obvious move is to go around it, and that is what the rest of the glutathione market sells. Each route is a separate question with its own evidence, so they do not inherit each other's results.

Under the tongue has the clearest head-to-head. Schmitt and colleagues ran a three-week randomised crossover comparing a sublingual glutathione against swallowed glutathione and against N-acetylcysteine. Total and reduced glutathione in plasma and the ratio of reduced to oxidised glutathione were higher on the sublingual form than on the swallowed form, though the p-value the authors attach there, p equal to 0.003, belongs to the ratio alone rather than to all three measures. The abstract reports one other p-value: plasma vitamin E rose significantly after the three weeks, p equal to 0.04, and only in the sublingual group. Before that becomes a recommendation, note the population: 20 volunteers, all of them with metabolic syndrome, over three weeks. That is a small crossover in people with a specific metabolic condition, and it does not transfer automatically to a healthy person in their twenties.

The buccal route, meaning a lozenge dissolved against the cheek, is the Handog study above, and it carries that study's limits: 30 women, open-label, no control group.

The two routes with their own pages. Liposomal glutathione wraps the molecule in a fat bubble to try to get it past the same enzymes, which is a different question from the one this page answers and it has its own trial evidence. Intravenous glutathione skips digestion entirely and comes with a regulatory picture that swallowed capsules do not have.

Does liposomal fix absorption Glutathione IV in Vietnam

The Liver Pitch

Glutathione gets sold for the liver almost as often as for skin, and there is one human study on swallowed capsules worth knowing about. Honda and colleagues ran an open-label, single-arm, multicentre pilot in 34 patients with nonalcoholic fatty liver disease diagnosed by ultrasound, of whom 29 finished. Every patient first spent 3 months improving diet and exercise, and only then took glutathione at 300 mg per day for 4 months. Alanine aminotransferase fell significantly by the end, along with triglycerides, non-esterified fatty acids and ferritin.

Now the design. There was no control group and no placebo, so nothing in the trial separates the capsule from the diet and exercise that came before it, from the extra attention 34 patients get in a study, or from ordinary variation in a liver enzyme that moves around on its own. The authors call it a pilot showing potential, and a pilot showing potential is exactly what it is. Anyone with a liver condition needs a doctor reading their own bloodwork, not a supplement aisle.

What Approved Means Here

Glutathione does appear in a United States government drug database, and that fact gets used as though it settles something. It does not. Being listed in a drug database is not the same as being approved, and the difference is easy to check. Filtering the United States FDA National Drug Code directory on the generic_name field for glutathione and the route field for oral returns 15 entries, and every one of them carries the marketing category unapproved homeopathic. The only glutathione entries in that whole directory holding an approved-application category are BSS Plus, under application NDA018469, which is a balanced salt solution used to irrigate the eye during surgery and is not swallowed.

That is United States data describing United States listings. It says nothing about how Vietnam's Ministry of Health classifies any specific imported product, and I have not checked that here. What it does show is that the swallowed capsules do not clear a drug approval anywhere in that record. Dilokthornsakul and colleagues describe glutathione as commonly used to lighten skin colour in Asia as a dietary supplement, and a supplement is a category where nobody had to prove the product works before it reached the shelf.

Which puts the burden on the buyer for two separate things: whether the compound does what the box says, and whether the box contains what it claims. The first is what this whole page is about. The second is a testing question, and the reference standard there is batch-level analysis from a lab that did not sell you the product. Our guide to reading a certificate of analysis covers how that works and what a real one looks like.

The Short Version

A single 3 g dose did not raise plasma glutathione over 270 minutes in 7 healthy volunteers, because gut and liver enzymes take the molecule apart.
Daily capsules over 6 months did raise body stores, 30 to 35 percent in red cells, plasma and lymphocytes at 1,000 mg per day, and those levels fell back to baseline one month after stopping.
The same 1,000 mg per day for only 4 weeks changed nothing measurable, so duration matters, not just the milligram number.
For skin, the effect shows up on sun-exposed areas and not on sun-protected ones, and two systematic reviews call the evidence inconclusive and the outcomes unsustainable.
The trials sit at 250 to 500 mg per day for skin and 250 to 1,000 mg per day for body stores, which leaves a 2,000 mg serving untested rather than proven stronger.
The glutathione plus vitamin C combination that was actually trialled did not separate from placebo over 12 weeks.
No swallowed glutathione product holds a drug approval in the United States FDA directory, and being listed there is not an approval.

Frequently Asked Questions

Does oral glutathione actually work?+

It depends entirely on what you mean by work and over what timescale. A single large oral dose does almost nothing: Witschi and colleagues gave 7 healthy volunteers a single dose of 0.15 mmol per kg, which they describe as 3 g, and plasma glutathione, cysteine and glutamate did not rise significantly over the following 270 minutes. Six months of daily capsules is a different story: in Richie and colleagues, 54 non-smoking adults split across a 250 mg group, a 1,000 mg group and a placebo group, glutathione in the 1,000 mg group rose 30 to 35 percent in red blood cells, plasma and lymphocytes at 6 months. Both results are real. They measured different things over very different windows, and product pages tend to quote whichever one flatters the bottle.

Is glutathione 2000mg better than 500mg?+

Nobody has published a human trial at 2,000 mg per day for the outcomes these bottles are sold for, so there is no honest way to say it is better. The trials that raised measurable body stores used 250 mg and 1,000 mg per day. The trials that reported a change in skin melanin index used 250 mg once a day, 250 mg twice a day, or 500 mg once a day. A 2,000 mg serving sits above every daily dose in that published set, which makes it untested rather than proven stronger. Worth noting in the other direction too: 1,000 mg per day for 4 weeks changed nothing in Allen and Bradley, so a bigger number is not a shortcut past the time it takes.

Does glutathione with vitamin C work better?+

The closest test of that combination did not separate from placebo. Sitohang and colleagues ran an Indonesian multicentre randomised double-blind trial, registered as NCT04105504, of a supplement combining L-glutathione, ascorbic acid, alpha-lipoic acid and zinc aspartate against placebo capsules over 12 weeks. 83 participants aged 33 to 50 completed, split between the supplement arm and the placebo arm. Reductions in ultraviolet spots in certain subgroups, spot polarisation and skin tone were greater on the supplement than on placebo, but the difference was not statistically significant. The authors concluded it was slightly beneficial in particular subgroups with results that were not statistically significant. A second problem with combination bottles: four active ingredients at once means even a clear result could not tell you which one did it.

Why do some studies say oral glutathione is not absorbed?+

Because of what they measured and when. Glutathione is hydrolysed by gamma-glutamyltransferase in the intestine and liver, which is the mechanism Witschi and colleagues named in 1992 when they found single-dose systemic availability to be negligible. Park and colleagues later added a wrinkle: after an oral dose of 50 mg per kg in healthy volunteers, there was no significant difference in the standard deproteinised plasma fraction or in the blood cell fraction, but glutathione in the protein-bound fraction of plasma rose significantly between 60 and 120 minutes. So the assay most studies run, free glutathione in plasma, is not looking everywhere the molecule can end up. That does not prove a benefit, it just explains why two honest labs can report different things.

Does oral glutathione lighten skin?+

The trials lean toward a small effect on sun-exposed skin and toward nothing on skin the sun does not reach, and the reviews call the overall evidence inconclusive. In a Bangkok trial of 60 otherwise healthy medical students randomised to 500 mg per day or placebo for 4 weeks, melanin indices fell at all six measured sites in the glutathione group, but the reduction beat placebo at two of those six, the right side of the face and the sun-exposed left forearm. A systematic review by Dilokthornsakul and colleagues found oral 500 mg per day brightened sun-exposed areas, while no product produced a significant reduction in sun-protected areas, and concluded the evidence is still inconclusive because of study quality and inconsistent findings. None of the skin trials on this page ran longer than 12 weeks.

Do the effects last after you stop?+

The published picture says no. Richie and colleagues measured glutathione levels again after a one-month washout and they had returned to baseline. A 2025 systematic review of glutathione as a skin-lightening agent describes the skin outcomes as unsustainable. An earlier review by Sonthalia and colleagues describes the oral, sublingual and topical results on skin tone as appreciable but reversible. Three separate sources pointing the same direction is about as clear as this literature gets, and it is the part a bottle will never print on its label.

Is oral glutathione approved by a regulator?+

Not as a swallowed medicine in the United States, and appearing in a drug database is not the same as being approved. Filtering the US FDA National Drug Code directory on the generic_name field for glutathione and the route field for oral returns 15 entries, and every one of them carries the marketing category unapproved homeopathic. The only glutathione entries in that directory holding an approved-application category are BSS Plus under application NDA018469, a balanced salt solution used to irrigate the eye during surgery, which is not something you swallow. That is United States data about United States listings and says nothing about how Vietnam classifies a specific imported product. Glutathione is commonly sold across Asia as a dietary supplement, which means nobody had to prove it works before it reached the shelf.

Research And Sources

Every figure on this page comes from one of the papers below, read as published abstracts, plus one query against the openFDA drug directory. Where a study hedged, the hedge is carried through.

The systemic availability of oral glutathione · Witschi A, Reddy S, Stofer B, Lauterburg BH · European Journal of Clinical Pharmacology (1992) PMID:1362956
Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers · Allen J, Bradley RD · Journal of Alternative and Complementary Medicine (2011) PMID:21875351
Randomized controlled trial of oral glutathione supplementation on body stores of glutathione · Richie JP Jr, Nichenametla S, Neidig W, et al. · European Journal of Nutrition (2015) PMID:24791752
Increase in the protein-bound form of glutathione in human blood after the oral administration of glutathione · Park EY, Shimura N, Konishi T, et al. · Journal of Agricultural and Food Chemistry (2014) PMID:24877771
Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: A comparative crossover study · Schmitt B, Vicenzi M, Garrel C, Denis FM · Redox Biology (2015) PMID:26262996
Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study · Arjinpathana N, Asawanonda P · Journal of Dermatological Treatment (2012) PMID:20524875
Glutathione and its antiaging and antimelanogenic effects · Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P · Clinical, Cosmetic and Investigational Dermatology (2017) PMID:28490897
An open-label, single-arm trial of the safety and efficacy of a novel preparation of glutathione as a skin-lightening agent in Filipino women · Handog EB, Datuin MS, Singzon IA · International Journal of Dermatology (2016) PMID:26148180
Evaluating Oral Glutathione Plus Ascorbic Acid, Alpha-lipoic Acid, and Zinc Aspartate as a Skin-lightening Agent: An Indonesian Multicenter, Randomized, Controlled Trial (NCT04105504) · Sitohang IBS, Anwar AI, Jusuf NK, et al. · Journal of Clinical and Aesthetic Dermatology (2021) PMID:34840651
The clinical effect of glutathione on skin color and other related skin conditions: A systematic review · Dilokthornsakul W, Dhippayom T, Dilokthornsakul P · Journal of Cosmetic Dermatology (2019) PMID:30895708
Glutathione as a skin-lightening agent and in melasma: a systematic review · Sarkar R, Yadav V, Yadav T, P J, Mandal I · International Journal of Dermatology (2025) PMID:39444151
Glutathione for skin lightening: a regnant myth or evidence-based verity? · Sonthalia S, Jha AK, Lallas A, Jain G, Jakhar D · Dermatology Practical & Conceptual (2018) PMID:29445569
Efficacy of glutathione for the treatment of nonalcoholic fatty liver disease: an open-label, single-arm, multicenter, pilot study · Honda Y, Kessoku T, Sumida Y, et al. · BMC Gastroenterology (2017) PMID:28789631